Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes. [electronic resource]
Producer: 20000920Description: 51-7 p. digitalISSN:- 0270-4137
- Adenocarcinoma -- drug therapy
- Aged
- Androgen Antagonists -- administration & dosage
- Androgens -- physiology
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biopsy, Needle
- Cell Differentiation -- drug effects
- Flutamide -- administration & dosage
- Gonadotropin-Releasing Hormone -- agonists
- Humans
- Immunohistochemistry
- Macrophage Migration-Inhibitory Factors -- biosynthesis
- Male
- Middle Aged
- Neoadjuvant Therapy
- Prognosis
- Prostate -- metabolism
- Prostatic Intraepithelial Neoplasia -- drug therapy
- Prostatic Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.